Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
987
-
Total 13F shares, excl. options
-
125,053,711
-
Shares change
-
+1,075,986
-
Total reported value, excl. options
-
$34,758,696,486
-
Value change
-
+$300,589,329
-
Put/Call ratio
-
87%
-
Number of buys
-
409
-
Number of sells
-
-454
-
Price
-
$278.03
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q1 2023
1,150 filings reported holding BIIB - BIOGEN INC. - COM as of Q1 2023.
BIOGEN INC. - COM (BIIB) has 987 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 125,053,711 shares
of 146,614,676 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16,001,166 shares), BlackRock Inc. (13,986,221 shares), VANGUARD GROUP INC (12,157,662 shares), STATE STREET CORP (6,757,000 shares), WELLINGTON MANAGEMENT GROUP LLP (5,452,888 shares), JPMORGAN CHASE & CO (4,108,863 shares), GEODE CAPITAL MANAGEMENT, LLC (3,102,735 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,088,356 shares), Clearbridge Investments, LLC (1,864,745 shares), and FMR LLC (1,752,614 shares).
This table shows the top 987 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.